Die Infektion einer Zelle und die Virus-Ausbreitung von Zelle zu Zelle in infiziertem Gewebe oder in der Zellkultur ist abhängig von der Fähigkeit des Virus, die Fusion von Membranen zu induzieren und somit die natürliche Barriere zwischen einzelnen Zellen zu überwinden. Neben den viralen Glykoproteinen sind dabei Proteine in der Membran der Wirtszelle ausschlaggebend für einen erfolgreichen Ablauf dieser Fusionsprozesse. Kürzlich konnten wir mit CD9, einem Mitglied der Tetraspann-Transmembran-Proteinfamilie, ein zelluläres Oberflächenmolekül identifizieren, welches bei einer Infektion von Zellen mit CDV an diesen Fusionvorgängen beteiligt ist: Transfektion eines CD9-Expressionsplasmids in CD9-negative Zellen erhöht deren Infizierbarkeit und CD9-Antikörper inhibieren die Infektion von Zellkulturen mit CDV (OND). In der vorliegenden Arbeit wurde untersucht, welcher Mechanismus hinter der Hemmung der CDV-Infektion durch CD9-Antikörper steht. Es besteht keine Korrelation zwischen der Expression von CD9 und der Virusbindung an Zellen besteht. Zudem konnte mit Antikörpern gegen CD9 die Bindung von CDV an Zellen nicht beeinträchtigt werden. Es konnte des weiteren kein unmittelbarer Effekt von CD9-Antikörpern auf die Virusaufnahme, sowie auf die virale mRNA- und Protein-Synthese festgestellt werden. Auch die posttranslationale Modifikation der viralen Proteine, wie die Spaltung des F0-Proteins in F1 und F2, und ihre Expression an der Zelloberfläche verläuft in Gegenwart von mAK K41 normal. Durch Antikörper gegen CD9 wird jedoch die Synzytienbildung in infizierten Zellkulturen stark gehemmt und die Freisetzung neuer Viruspartikel verringert. Untersuchungen der Fusion von uninfizierten mit persistent CDV-infizierten HeLa-Zellen zeigten, dass mAK K41 direkt die CDV-induzierte Zell-Zell-Fusion beeinflusst. Dabei wird aber kein Teilschritt des Fusionsprozesses, wie z.B. die Hemifusion, vollständig blockiert, da die Synzytienbildung selbst durch den Einsatz hoher Konzentrationen an mAK K41 nicht verhindert werden kann. Die Reduktion der Virustiter und der viralen mRNA-Mengen, die man etwa ab 18 Stunden nach Infektion in Gegenwart von mAK K41 beobachtet, entspricht der Reduktion, die man in Gegenwart eines fusionsinhibierenden Peptids (FIP) beobachtet. In beiden Fällen ist diese Reduktion höchstwahrscheinlich ein Sekundäreffekt der Inhibition der Infektionsaus-breitung durch Synzytienbildung.Bei CDV kann zwischen Stämmen, die Synzytien induzieren und Stämmen, die in infizierten Zellkulturen keine oder nur sehr geringe Plaquebildung zeigen, unterschieden werden. Diese Unterschiede basieren auf Sequenzunterschieden in den viralen Glykoproteinen H und F, die bei Morbilliviren für die Art des zytopatischen Effekts verantwortlich sind. Bei den Stämmen, die keine Synzytien induzieren, und dem Wildstamm A75/17 haben Antikörper gegen CD9 keinen inhibierenden Effekt auf die Infektion und es sind in Zellkulturen keine Unterschiede im Infektionsverlauf in An- oder Abwesenheit von mAK K41 zu beobachten. Die Hemmbarkeit einer CDV-Infektion durch CD9-Antikörper ist also abhängig von der Fähigkeit des jeweiligen Stammes Synzytien zu induzieren.Aus den vorliegenden Daten kann geschlossen werden, das CD9-Antikörper spezifisch die CDV-induzierte Zell-Zell-Fusion hemmen, nicht aber die Virus-Zell-Fusion. Im Gegensatz zur Virus-Zell-Fusion scheint die virusstammspezifischen Induktion der Zell-Zell-Fusion, neben dem zellulären Rezeptormolkül noch von weiteren Interaktionen der viralen Hüllproteine mit anderen Zelloberflächenmolekülen abhängig zu sein. Es ist anzunehmen, dass CD9 dabei direkt oder indirekt mit diesen Oberflächenmolekülen interagiert und somit Einfluß auf die Zellfusion hat. Bei der CDV-Infektion bewirken CD9-Antiköper eine Verzögerung der Synzytienbildung, während sie bei der NDV-Infektion zu einer verstärkten Synzytienbildung führen.Neben dem bereits bekannten fusionregulierenden Protein FRP-1/CD98 konnte so mit CD9 ein weiteres Membranprotein identfiziert werden, das an der Regulierung verschiedener viral-induzierter Zellfusionsvorgänge, aber auch an Zellfusionen im Zuge der Zelldifferenzierung und Entwicklung beteiligt ist. Die Regulierung der Fusion scheint aber bei CD9 und FRP-1 auf unterschiedlichen Mechanismen zu beruhen, da Antikörper gegen die beiden Membran-proteine bei NDV-infizierten Zellen die Zell-Zell-Fusion stimulieren, FRP-1-Antikörper aber keinen Einfluß auf die CDV-induzierte Zellfusion haben. Obwohl einige Interaktionspartner von CD9, wie z.B. Integrine, bekannt sind, konnte der Mechanismus der Regulation der Zell-Zell-Fusion durch CD9-Antikörper noch nicht aufgeklärt werden. Die vorliegende Arbeit zeigt zum ersten mal Unterschiede in der Virus-Zell- und Zell-Zell-Fusion bei Paramyxoviren auf und ist ein erster Schritt zu einem besseren Ver-ständnis des Unterschiedes zwischen zellulären und viralen Fusionsvorgängen. / Infection of cells and the cell-to-cell spread of a virus in infected tissues as well as in tissue culture depends on the capacity of the virus to induce membrane fusions overcoming the natural barriers between cells. Apart from the viral glycoproteins host cell membrane proteins are essential for successful fusion events. Recently, we found that in CDV infected cell cultures CD9, a member of the tetraspan transmembrane 4 superfamily, takes part in these fusion processes: Expression of CD9 in CD9-negative cell lines enhanced CDV infection, whereas anti-CD9 antibodies inhibited the infection of cells with the Onderstepoort strain of CDV.In this thesis I investigated which step of the CDV-infection is impaired by anti-CD9 antibodies. There is no correlation between the CD9-expression level and the binding of virus to target cells. Moreover antibodies against CD9 do not impair the binding of virus to cells. Neither the virus uptake, nor viral mRNA or protein levels are directly affected by anti-CD9-antibodies. Furthermore, the processing of viral proteins including cleavage of the F protein and the surface expression of viral proteins appears to be normal in presence of mAb K41. However, what is drastically affected by mAb K41 is the syncytium formation in infected cultures and virus release. In a fusion assay of uninfected with persistently infected HeLa cells, we found that mAb K41 directly impaires the CDV-induced cell-cell fusion. Yet none of the single steps of a fusion event, like f.e. hemifusion, is totally blocked, since even large amounts of mAb K41 cannot abolish the formation of syncitia.The reductions of the virus yield and of viral mRNA levels observed late after infection in the presence of mAb K41 are similar to those observed in the presence of a fusion inhibiting peptide (FIP), and therefore most likely are a secondary effect of the inhibition of syncytium formation.In case of CDV one can differentiate between syncytium-inducing strains and strains which don´t induce the formation of syncytia in infected cell cultures. This is propably due to sequenz differences of the H and F glycoproteins, which govern the type of cytopathic effect of Morbilliviruses. In cultures infected with non-syncitium-inducing strains or the wildstrain A75/17 anti-CD9-antibodies show no sign of inhibiting the infection and there is no difference in the progress of CDV-infection in absence or presence of mAb K41. Therefore the possibility to inhibit a CDV-infection by anti-CD9-antibodies depends on whether the used strain induces syncytium-formation or not.From these data we conclude that antibodies against CD9 specifically inhibit the CDV-induced cell-cell fusion, but not the virus-cell fusion. This indicates that the cell-to-cell spread and the infection of cells with extracellular virus are differentially regulated steps dependent on certain combinations and interactions of viral envelope proteins and cell surface molecules. It is probable that CD9 influences cell-cell-fuion by direct or indirect interaction with these surface molecules. CD9-antibodies delay the CDV-induced syncytium-formation and stimulate the NDV-induced syncytium-formation.Beside the allready known fusion regulation proteins FRP-1/CD98 and FRP-2 we found in CD9 another membrane protein that is involved in cell-cell-fusion induced by viruses or induced in the course of cell-differentiation and development. However, the mechanism by which CD9 and FRP-1/CD98 regulate fusion seem to be different, since antibodies against both proteins stimulate the NDV-induced cell-fusion but FRP-1-antibodies show no effect on CDV-induced cell-fusion.Although molecules interacting with CD9, such as integrins, are known, the mechanismus by which antibodies to CD9 regulate cell-cell fusion could not be unraveled yet. The presented thesis demonstrates for the first time differences in virus-cell fusion and cell-cell fusion induced by paramyxoviruses and is a first step for the understanding of differences between viral and cellular fusion processes.

Würzburg, Univ., Diss., 2001. / Erscheinungsjahr an der Haupttitelstelle: 2001

La fécondation est la rencontre de deux gamètes. Bien que centrale chez les espèces sexuées, les mécanismes membranaires et moléculaires ne sont pas encore établis. La communauté scientifique bute toujours sur la question centrale : Comment le spermatozoïde fusionne-t-il avec l’ovule ? Si des études ont identifié trois protéines essentielles : Izumo1, Juno et CD9, elles montrent aussi que ces acteurs ne sont pas suffisants. Notre étude a eu pour but d’identifier d’autres paramètres potentiels impliqués dans cette machinerie de fusion. Nous nous sommes donc focalisés sur la contribution des lipides spermatiques et sur celle du battement du flagelle. Nous avons développé deux méthodes expérimentales originales. Avec la première, qualifiée de « Bottom-up », nous avons tenté de déterminer la machinerie spermatique minimale pour induire la fusion avec l’ovocyte. L’idée a été de reconstituer pas à pas la membrane de la tête du spermatozoïde, d’abord avec les lipides identifiés lors d’analyses, puis en y incorporant Izumo1. Pour la seconde approche, appelée « Top-down », nous avons développé un outil microfluidique pour guider le spermatozoïde jusqu’à l’ovocyte afin de suivre la rencontre avec le « meilleur » point de vue, dans des conditions in-vitro aussi physiologiques que possible. Nous avons découvert que contrairement à ce que nous pensions, le battement du flagelle ne sert pas uniquement à atteindre l'ovocyte, mais aussi à déclencher la fécondation. En effet, les contraintes mécaniques induisent une réorganisation de la membrane ovocytaire incluant la protéine CD9. Ainsi, la chronologie des événements a pu être obtenue avec une résolution temporelle inégalée. / Fertilization is the encounter of two gametes. Although this process is crucial for sexual organisms, the timeline of the molecular events is not yet established. The researchers cannot explain: how the spermatozoon fuses with the oocyte? One of the reasons is the lack of experimental methods available. Indeed, the gametes need a specific environment to fertilize. Nevertheless, the scientific community identified three essential proteins: Izumo1 on the spermatozoon, Juno (its receptor) and CD9 on the oocyte membrane. For our part, we tried to determine if the none-proteins environment of Izumo1 and CD9 could influence the gametic interaction. To do so, we were focused on the role of the lipids composition of the sperm membranes and on the influence of the forces developed by the flagellum beating on the oocyte. We designed two original experimental methods to offer a better understanding of the mechanisms inside the gamete contact area. With the first one, we tried to identify the minimal machinery to induce fusion. We started to reconstitute step by step the membrane of the spermatozoon head. We tested first the identified lipids alone, and then we coupled these molecules with Izumo1. With the second one, we developed a microfluidic tool to observe the gametic encounter with the “best” viewpoint in the most physiological in-vitro conditions. We observed that the flagellum beating is not only involved in the crossing of the female genital tract but also in the initiation of the fusion step. Indeed, the mechanical constraints induce membrane reorganization with CD9 recruitment. So we succeed to establish the kinetic of the events with an unequaled resolution.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20606号 / 医博第4255号 / 新制||医||1023(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 羽賀 博典, 教授 篠原 隆司, 教授 近藤 玄 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

La thrombopoïétine (TPO) favorise successivement la prolifération et la maturation des progéniteurs mégacaryocytaires, soulevant la question du mécanisme expliquant cette dualité d'action. La signalisation SCF/ c-Kit est essentielle pour la prolifération de tous les progéniteurs hématopoïétiques, alors que l'extinction de l'expression du récepteur c-Kit est requise pour l'engagement en différenciation terminale. Réciproquement, l'équipe a montré que la stimulation de la voie Notch affecte une sous-population de progéniteurs bipotents érythro-mégacaryocytaires exprimant fortement CD9 (tétraspanine induite durant la maturation mégacaryocytaire) et favorise la reprise de leurs divisions au détriment de leur différenciation mégacaryocytaire terminale. Cet effet de la voie Notch s'accompagne d'une augmentation de l'expression de c-Kit. Ces observations m'ont conduite à m'intéresser aux mécanismes de régulation de c-Kit par la TPO en m'appuyant sur un modèle de progéniteurs bipotents immortalisés et dont la prolifération est strictement dépendante de la TPO (cellules G1ME). Les travaux réalisés durant ma thèse m'ont permis d'établir que (i) La stimulation des cellules G1ME par le ligand de Notch DLL1 favorise l'expression de c-Kit et réprime celle de CD9 (ii) L'activation inattendue de c-Kit par la TPO contribue à la prolifération (iii) c-Kit contribue activement à restreindre la polyploïdisation des cellules G1ME en présence de TPO (iv) La tétraspanine CD9 elle-même réprime l'expression de c-Kit à la membrane. Sur la base de ces résultats, nous proposons le modèle selon lequel, la TPO participerait à la fois à la prolifération des progéniteurs du fait de sa capacité à activer c-Kit, mais contribue aussi à l'augmentation de l'expression de CD9 qui en atteignant un seuil suffisant conduit à l'extinction de l'expression de c-Kit à la surface, entrainant alors l'arrêt des divisions et la différenciation mégacaryocytaire terminale / The Thrombopoietin (TPO) favors both the proliferation and the maturation of megakaryocytic progenitors, raising the question of the molecular mechanism explaining its dual function. SCF/ c-Kit signaling is essential for all hematopoietic progenitors amplification, whereas terminal differentiation requires the extinction of c-Kit receptor expression. Reciprocally, we evidenced in our team that Notch stimulation enables the induction of c-Kit expression and act on a particular subpopulation of bipotent erythro-megakaryocytic progenitors highly expressing the tetraspanin CD9 (induced during megakaryocytic maturation) and favors their re-entry in a cycling state by blocking their megakaryocytic maturation. These observations lead to the investigation of the molecular mechanism of c-Kit regulation by TPO in a cellular model of bipotent progenitors immortalized and dependent on TPO, the G1ME cells. During my thesis, I evidenced that: i) Notch stimulation induces the expression of c-Kit while repressing CD9 expression; ii) Surprisingly TPO is able to activate c-Kit allowing its contribution to cell proliferation; iii) c-Kit also represses megakaryocytic polyploidization (endomitosis characterizing megakaryocytic maturation) of G1ME cells; iv) The tetraspanin CD9 represses the expression of c-Kit. The ensemble of these data allows us to propose the following model wherein TPO activates c-Kit allowing the proliferation of megakaryocytic progenitors, while concomitantly induces the expression of the tetraspanin CD9 that will reach a sufficient level to provoke the extinction of c-Kit expression at the cell surface, thus enabling the arrest of cell cycling progress and the engagement into terminal megakaryocytic maturation

Malgré l'amélioration des traitements, environ 20% des patients atteints de leucémie aigue lymphoblastiques (LAL) rechutent dans la moelle osseuse ou dans des sites extra-médullaires tels que les ovaires et les testicules, ce qui est particulièrement fréquent dans les rechutes tardives de LAL-B présentant un remaniement ETV6/RUNX1. Les travaux réalisés par Virginie Gandemer en 2007, ont montré que l'expression de CD9 permettait de distinguer les leucémies ETV6/RUNX1 des autres types de leucémie. Le gène CD9 code pour une protéine de la famille des tétraspanines dont l'expression a été corrélée avec le risque métastatique et la survie des patients. Par ailleurs il a été démontré que la protéine CD9 était impliquée dans le homing et la prise de greffe des cellules souches hématopoïétiques et leucémiques. Nous avons donc émis l'hypothèse qu'à travers ses propriétés fonctionnelles sur la migration et le homing, CD9 pourrait être un acteur clé des rechutes de LAL-B. Le but de ce travail de thèse était donc premièrement de déterminer le mode de régulation de CD9 dans les LAL-B ETV6/RUNX1 et deuxièmement de déterminer les effets de l'expression de CD9 sur la motilité et la prise de greffe des LAL-B. Les analyses préalablement réalisées au laboratoire avaient suggéré que CD9 pouvait être régulé par des miARNs. Nous avons identifié un cluster de 3 miARNs potentiellement impliqués dans la régulation de CD9 dans les LAL-B ETV6/RUNX1. Ces résultats doivent cependant être complétés par d'autres analyses fonctionnellles afin d'être confirmés. Nous avons étudié le rôle de la protéine CD9 dans la dissémination des cellules de LAL-B. Nous avons démontré que CD9 était un régulateur potentiel de l'adhésion et un nouveau facteur impliqué dans la migration et le homing dépendants de CXCR4 en favorisant l'activation de RAC1 et les réarrangements de l'actine en réponse au CXCL12. Enfin, nous avons décrit pour la première fois l'influence de CD9 sur la migration et le homing dans les testicules via RAC1. Nos résultats montrent donc que CD9 favorise la dissémination des cellules de LAL-B dans les testicules et suggèrent que cette protéine pourrait constituer un acteur majeur des rechutes tardives de LAL-B dont les mécanismes d'apparitions sont peu connus. / Despite improvements in survival rates, approximately 20% of children suffering from acute lymphoblastic leukemia (B-ALL) present relapses from bone marrow or from B-extramedullary sites, such as the testes or ovaries, particularly in cases of late relapse of ETV6/RUNX1-ALL. Virgine Gandemer showed in 2007, that the expression of CD9, a protein from the tetraspanin superfamily, can be used to distinguish ETV6/RUNX1 lymphoblastic leukemia from other types of ALL. CD9 expression has been correlated with the risk of metastasis and is associated with a poor clinical outcome in various types of cancer. Moreover CD9 has been implicated in hematopoietic and leukemic stem cell homing. We hypothesized, that CD9 protein, through its functional properties on migration and homing, could be a key actor of B-ALL relapses. The purpose of our study was then to investigate, first the transcriptional regulation of CD9 in ETV6/RUNX1 B-ALL and secondly, the effect of CD9 expression on motility and engrafment of B lymphoblasts. The analysis of CD9 transcriptional regulation previously made in the team, suggested that it could be regulated by miRNAs. We identified a cluster of 3 miRNAs potentially implicated in the regulation of CD9 expression in ETV6/RUNX1 B-ALL. This result has to be confirmd by more functional analysis. We investigated the role of CD9 in the dissemination of B-ALL. We identified CD9 as a potential regulator of B-ALL cell adhesion and a new factor involved in CXCR4-mediated migration and homing, through the promotion of actin rearrangement in response to CXCL12. We also characterized the effect of CD9 protein expression on RAC1 activation, which had an impact on blast migration and engraftment. Finally, we described, for the first time, the influence of CD9, mediated by RAC1 signaling, on B-cell chemotactic migration and homing in the testis. Our work provides evidence for an impact of CD9 on the ability of pre-B leukemic cells to disseminate to testes, through its effects on migration and homing, and suggests that CD9 may be a key player in late relapses of B-ALL, which are currently poorly understood.

Les leucémies aiguës lymphoblastiques (LAL) sont le cancer le plus fréquent chez l’enfant et dérivent le plus souvent de précurseurs lymphoïdes B. D’importants progrès thérapeutiques ont permis d’améliorer considérablement le pronostic. Néanmoins, 15 à 20 % des enfants rechutent encore. Ces rechutes peuvent survenir de façon isolée ou combinée dans la moelle osseuse, le site primitif des lymphoblastes, et/ou dans des organes extramédullaires tels que le testicule ou le système nerveux central. Notre équipe a montré que la protéine transmembranaire CD9 jouait un rôle majeur dans la migration des blastes dans ces sites et notamment le testicule, par l’activation de la voie RAC1 en réponse à la stimulation des cellules par le CXCL12. Ici, nous avons mis en évidence qu’un faible niveau d’oxygène, caractéristique commune aux niches médullaire et extramédullaires, régulait positivement l’expression de CD9 aux niveaux transcriptionnel et protéique, via la voie majeure de réponse à l’hypoxie, dépendante du facteur de transcription Hypoxia Inducible Factor 1a (HIF1a). Nous montrons que HIF1a se fixe directement sur le promoteur de CD9 pour induire sa transcription. Nous montrons aussi que la protéine CD9 est essentielle aux propriétés d’adhérence et de migration des blastes dans des conditions de basse oxygénation, et que son action pourrait s’exercer à travers RAC1 comme en normoxie. Nos résultats dans des expériences de xénogreffe à des souris indiquent que la voie HIF1a favorise la dissémination des blastes, possiblement à travers la régulation qu’elle exerce sur CD9. Ainsi, ce travail contribue à mieux comprendre le rôle de CD9 dans la pathogenèse des LAL de l’enfant. / Acute lymphoblastic leukemia (ALL) are the most frequent cancer in children and derive most often from B-cell precursors. Huge therapeutic improvements have allowed to reach high survival rates near 90% at 10 years from diagnosis. However, 15-20% of children still relapse with a significant risk of death. Relapses can occur in bone marrow and/or extramedullary sites such as testis or central nervous system, usually referred as “sanctuary sites”. Our previous work showed that the transmembrane protein CD9 plays a major role in lymphoblasts migration into these sites, especially in testis, through the activation of RAC1 signaling upon blasts stimulation with C-X-C chemokine ligand 12 (CXCl12). Here, we addressed the question of putative common factors shared by bone marrow and extramedullary niches which could upregulate CD9 expression and function. Consequently, we found that low oxygen levels could actually enhance CD9 expression both at mRNA and protein levels. We further determined that Hypoxia Inducible Factor 1a (HIF1a), the master transcription factor involved in hypoxia response, binds directly CD9 promoter to induce its transcription. We also showed that CD9 protein is crucial for leukemic cell adhesion and migration at low oxygen levels, possibly through its action on RAC1 signaling. Mouse xenograft experiments indicate that HIF1a signaling pathway favors ALL cells dissemination, which may involve CD9 as well. The present work increments our understanding of CD9 implication in ALL pathogenesis.

Research Doctorate - Doctor of Philosophy (PhD) / Membrane fusion events are a fundamental aspect of cellular biology and underpin important processes such as organ formation and fertilisation. Within the latter, proteins that are expressed on the egg surface which are responsible for mediating sperm recognition, binding and fusion to the egg, are yet to be fully determined. Evidence does however suggest that egg surface glycophosphatidylinositol (GPI)-anchored proteins play a role in sperm binding, whilst another class of proteins, known as tetraspanins, appear to be important in downstream events of membrane fusion. Of the tetraspanins, CD9 and CD81 have been identified as fulfilling roles in membrane fusion; identifications are however yet to obtained for the important GPI-anchored protein(s). This research aimed to identify and characterise egg surface proteins implicated in sperm-egg interaction, and embodied attempts to both identify the important GPI-anchored protein(s) as well as expand upon tetraspanin studies through investigations into mice lacking the tetraspanin CD151. Throughout this research, it was hypothesised that membrane fusion events of fertilisation parallelled those of enveloped virus – host cell fusion, for which rearrangement of surface protein thiols is essential. In vitro binding and fusion experiments were utilised as functional bioassays in the investigation of factors affecting sperm-egg interaction, such as tetraspanin deletion and the xenobiotic modification of cell surface thiols, while mass spectrometry (MS)-based proteomics and bioinformatics-based analyses were employed to compile oocyte protein databases and to identify candidate proteins responsible for mediating sperm-egg interaction, such as GPI-anchored proteins. It was determined that exposing oocytes to compounds with a capacity to alkylate cell surface thiols strongly inhibited sperm-egg binding. Additionally, while CD151 deletion had no effect on sperm-egg binding, the downstream events of membrane fusion were significantly impaired. Ovaries from CD151 null mice also exhibited abnormal phenotypes. In addition, a total of 11 identifications were obtained in the search for the GPI-anchored proteins expressed within eggs, however only 6 of these were deemed to be potential mediators of sperm-egg interaction. In conclusion, the experiments outlined herein demonstrate a novel inhibitory effect for specific xenobiotics on sperm-egg interaction, and correlate the inhibitory action of these compounds with their capacity to reduce cell surface thiol labelling. A novel role for CD151 in the mediation of sperm-egg fusion was also discovered, while at the same time the important GPI-anchored protein(s) implicated in sperm-egg binding may be among 6 identified potential candidates. Together the findings reiterate the consensus that oocytes possess a cell surface protein complex responsible for mediating sperm binding and fusion as separate events, and in light of the demonstrated importance of surface thiols, that events of sperm-egg membrane fusion parallel those of enveloped virus – host cell fusion.

Research Doctorate - Doctor of Philosophy (PhD) / Membrane fusion events are a fundamental aspect of cellular biology and underpin important processes such as organ formation and fertilisation. Within the latter, proteins that are expressed on the egg surface which are responsible for mediating sperm recognition, binding and fusion to the egg, are yet to be fully determined. Evidence does however suggest that egg surface glycophosphatidylinositol (GPI)-anchored proteins play a role in sperm binding, whilst another class of proteins, known as tetraspanins, appear to be important in downstream events of membrane fusion. Of the tetraspanins, CD9 and CD81 have been identified as fulfilling roles in membrane fusion; identifications are however yet to obtained for the important GPI-anchored protein(s). This research aimed to identify and characterise egg surface proteins implicated in sperm-egg interaction, and embodied attempts to both identify the important GPI-anchored protein(s) as well as expand upon tetraspanin studies through investigations into mice lacking the tetraspanin CD151. Throughout this research, it was hypothesised that membrane fusion events of fertilisation parallelled those of enveloped virus – host cell fusion, for which rearrangement of surface protein thiols is essential. In vitro binding and fusion experiments were utilised as functional bioassays in the investigation of factors affecting sperm-egg interaction, such as tetraspanin deletion and the xenobiotic modification of cell surface thiols, while mass spectrometry (MS)-based proteomics and bioinformatics-based analyses were employed to compile oocyte protein databases and to identify candidate proteins responsible for mediating sperm-egg interaction, such as GPI-anchored proteins. It was determined that exposing oocytes to compounds with a capacity to alkylate cell surface thiols strongly inhibited sperm-egg binding. Additionally, while CD151 deletion had no effect on sperm-egg binding, the downstream events of membrane fusion were significantly impaired. Ovaries from CD151 null mice also exhibited abnormal phenotypes. In addition, a total of 11 identifications were obtained in the search for the GPI-anchored proteins expressed within eggs, however only 6 of these were deemed to be potential mediators of sperm-egg interaction. In conclusion, the experiments outlined herein demonstrate a novel inhibitory effect for specific xenobiotics on sperm-egg interaction, and correlate the inhibitory action of these compounds with their capacity to reduce cell surface thiol labelling. A novel role for CD151 in the mediation of sperm-egg fusion was also discovered, while at the same time the important GPI-anchored protein(s) implicated in sperm-egg binding may be among 6 identified potential candidates. Together the findings reiterate the consensus that oocytes possess a cell surface protein complex responsible for mediating sperm binding and fusion as separate events, and in light of the demonstrated importance of surface thiols, that events of sperm-egg membrane fusion parallel those of enveloped virus – host cell fusion.

Sperm-­-egg membrane interaction and fusion is mediated by various molecules of the different protein network that are located on both egg and sperm membrane. So far, many proteins have been selected to be fusion candidates, some of them (Izumo1, CD9, Juno) were proven to be essential, whereas others were discovered to play an unsuspected new active role (CD46, tetraspanins). After the adhesion of sperm to an egg, Juno located on the oolema associates with monomeric Izumo1 on sperm membrane, which is results in Izumo1 dimerization following quick removal of Juno from the egg surface as described in mouse. It implies that additional receptor on the egg membrane is required to play a role in sperm-­-egg fusion. To find a human fusogenic receptor for IZUMO1 protein we used one-­-bead-­-one-­-compound (OBOC) assay, a random screening approach. A bead, fulfilling all the requirements when interacting with the human sperm, carried a peptide sequence showing homology with the conserved Ig domain of the human specific Fc receptor-­-like protein 3 (FcRL3). In general, the ...